Non-palpable breast lesions
Citation, DOI, disclosures and article data
At the time the article was created Paresh K Desai had no recorded disclosures.View Paresh K Desai's current disclosures
At the time the article was last revised Gerard Carbo had no recorded disclosures.View Gerard Carbo's current disclosures
With increasing use of screening mammography and ultrasound for various indications, a large number of non-palpable breast lesions are being detected.
Among this large number of non-palpable masses, not all are malignant. The incidence of malignancy among these non-palpable lesions varies between 20-30%.
The radiologist plays an important role in the further work up and management of this subset of patients.
What role can we as radiologists play?
- be careful in evaluating any breast lesion; comparison with previous images is invaluable; lesions that change over time is a significant finding but is not necessarily a predictor of malignancy.
- be sure not to overdiagnose
- rule out pseudo mass lesions; if necessary, perform extra views in mammography like magnification views
- use ultrasound to correlate the abnormal findings on mammography.
- can perform wire needle localization of non-palpable lesions detected by mammography which are not seen on ultrasound
- can use same procedure of stereotactic biopsy to place a hook wire in the center of the lesion
- following the excision, can do specimen mammography to ensure that there is an adequate margin by comparing the specimen mammogram with the preoperative mammograms
- the suspicious lesion may be just a cluster of microcalcifications
- in such cases, we need to be careful evaluating adequate margins on specimen mammogram
- in lesions seen on ultrasound, needle placement can be done under sonographic guidance. In such cases, intraoperative sonography can be performed to assess complete removal
- ultrasound-guided FNAC/biopsy can be performed preoperatively.
- recent technique of radionuclide localization (ROLL) is emerging as an adjunct.
To be convinced a lesion is benign, the lesion has to always be benign/innocuous on
- clinical exam
- breast imaging, i.e. mammography, ultrasound and or MRI or a combination of each
- tissue sampling (cytology or histology)
If one of the three bullets above is not satisfied, the lesion cannot simply be called benign. If the lesion is clinically suspicious and even if imaging is negative, cytology is indicated. If the lesion is palpable and not seen on mammogram ultrasound is mandatory and unless the ultrasound is convincingly benign, tissue sampling is indicated.
- 1. Ohsumi S, Takashima S, Aogi K et-al. Breast biopsy for mammographically detected non-palpable lesions using a vacuum-assisted biopsy device (Mammotome) and an upright-type stereotactic mammography unit. Jpn. J. Clin. Oncol. 2001;31 (11): 527-31. Jpn. J. Clin. Oncol. (link) - Pubmed citation
- 2. Pisano ED, Fajardo LL, Caudry DJ et-al. Fine-needle aspiration biopsy of nonpalpable breast lesions in a multicenter clinical trial: results from the radiologic diagnostic oncology group V. Radiology. 2001;219 (3): 785-92. Radiology (full text) - Pubmed citation